BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 2177396)

  • 1. Modification of natural killer activity of lymphocytes infiltrating human lung cancers.
    Anderson TM; Ibayashi Y; Holmes EC; Golub SH
    Cancer Immunol Immunother; 1987; 25(1):65-8. PubMed ID: 3109739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
    Roussel E; Gingras MC; Grimm EA; Roth JA
    Cancer Immunol Immunother; 1995 Jul; 41(1):1-9. PubMed ID: 7641214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2.
    Whiteside TL; Heo DS; Takagi S; Johnson JT; Iwatsuki S; Herberman RB
    Cancer Immunol Immunother; 1988; 26(1):1-10. PubMed ID: 3257898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
    Uchida A; Moore M
    Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.
    Radrizzani M; Gambacorti-Passerini C; Parmiani G; Fossati G
    Cancer Immunol Immunother; 1989; 28(1):67-73. PubMed ID: 2462469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of recombinant-interleukin-2-activated peripheral blood and tumor-infiltrating lymphocytes of patients with epithelial ovarian carcinoma: cytotoxicity, growth kinetics and phenotype.
    Lotzová E; Savary CA; Freedman RS; Edwards CL; Morris M
    Cancer Immunol Immunother; 1990; 31(3):169-75. PubMed ID: 2337905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients.
    Inoue Y; Shijubo N; Uede T
    Jpn J Cancer Res; 1990 Oct; 81(10):1012-20. PubMed ID: 2172193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice.
    Ames IH; Gagne GM; Garcia AM; John PA; Scatorchia GM; Tomar RH; McAfee JG
    Cancer Immunol Immunother; 1989; 29(2):93-100. PubMed ID: 2720709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma.
    Chao TY; Chu TM
    Cancer Immunol Immunother; 1989; 30(3):158-64. PubMed ID: 2598184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.
    Mazumder A; Grimm EA; Rosenberg SA
    Cancer Immunol Immunother; 1983; 15(1):1-10. PubMed ID: 6603260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S; Whiteside TL; Moretta L; von Fliedner V
    J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of natural killer cells in cancer.
    Pross HF; Lotzová E
    Nat Immun; 1993; 12(4-5):279-92. PubMed ID: 8257832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human circulating and tumor-infiltrating lymphocytes in cancer defense and treatment.
    Lotzová E
    Nat Immun Cell Growth Regul; 1990; 9(4):253-64. PubMed ID: 2215514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor activity of human tumor infiltrating lymphocytes (TIL) and its comparison with peripheral blood lymphocytes (PBL)].
    Xu ZY
    Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):345-7. PubMed ID: 2177396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
    Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with autologous tumor-infiltrating lymphocytes and recombinant interleukin-2 in patients with lung carcinoma].
    Li D; Zhang X; Song Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):152-5. PubMed ID: 7656811
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.